Abstract
(465) An open-label, multicenter study of the safety of twice daily oxycodone hydrochloride controlled-release tablets in opioid experienced children from ages 6 to 16 years old, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid analgesics
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
